Transitional care for inflammatory bowel disease: A survey of Japanese pediatric gastroenterologists

Hideki Kumagai1, Takahiro Kudo2, Keiichi Uchida3

  • 1Department of Pediatrics, Jichi Medical University, Shimotsuke City, Tochigi, Japan.

Insights

Pediatric gastroenterologists largely agree with adult specialists on transitional care for pediatric-onset inflammatory bowel disease (IBD), but differ on the ideal transfer age. Preparing tailored transition programs is crucial for effective IBD care.

Area of Science:

  • Gastroenterology
  • Pediatric Medicine
  • Healthcare Management

Background:

  • Previous research reported adult gastroenterologists' views on transitional care for childhood-onset inflammatory bowel disease (IBD).
  • This study surveyed pediatric gastroenterologists to compare their perspectives with adult specialists on IBD transitional care.

Purpose of the Study:

  • To compare the views of pediatric and adult gastroenterologists on transitional care for patients with childhood-onset IBD.
  • To identify challenges and ideal practices in transitioning IBD patients from pediatric to adult care.

Main Methods:

  • A survey was distributed to 48 members of the Japanese Society for Pediatric Gastroenterology, Hepatology and Nutrition.
  • Respondents ranked the importance of statements regarding transitional care using a Likert scale.
  • The survey achieved a 79% response rate, with 60% of respondents having experience with IBD transitional care.

Main Results:

  • 90% of pediatric gastroenterologists viewed transfer to adult care as ideal for adolescents/young adults with IBD.
  • 59% reported difficulties in the referral process for transitional care.
  • The ideal transfer age was considered to be 18-22 years by most respondents.
  • Physicians in municipal hospitals cited comorbidities and staffing shortages as significant challenges.

Conclusions:

  • Pediatric and adult gastroenterologists share similar views on IBD transitional care, with notable differences in the preferred age for transfer.
  • The findings highlight the necessity of developing practice-specific transition programs for IBD patients.
  • Addressing challenges such as staffing and comorbidities is essential for optimizing transitional care.
Abstract

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
343
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
545
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
344
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
792
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
335
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
735